Novocure

Novocure is a global oncology company pioneering a novel therapy called Tumor Treating Fields (TTFields) for the treatment of solid tumors. TTFields therapy uses electric fields tuned to specific frequencies to disrupt cancer cell division, inhibiting tumor growth and potentially causing cancer cell death. The company focuses on developing TTFields for various types of cancer, including glioblastoma, non-small cell lung cancer, pancreatic cancer, ovarian cancer, and more. Novocure’s innovative approach offers a non-invasive treatment option that can be used in combination with other cancer therapies, such as chemotherapy and radiation. The company is committed to advancing clinical research and has multiple ongoing clinical trials to expand the application of TTFields. Novocure collaborates with leading cancer centers and research institutions worldwide to enhance the understanding and effectiveness of its therapy. The company also provides comprehensive support programs for patients and healthcare providers to ensure optimal treatment outcomes. With a mission to extend survival in some of the most aggressive forms of cancer, Novocure continues to push the boundaries of cancer treatment through innovation and dedication.